Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and COVID-19 Severity and Mortality Among US Veterans

NCT04467931 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT04467931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04467931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and COVID-19 Severity and Mortality Among US Veterans
Lead sponsor
University of Utah
Phase
Observational
Overall status
Completed
Start date
January 19, 2020
Completion date
December 31, 2020
Enrollment
22,213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid, hypertension